Amyloids, aggregates and Nucleolar activity in Xenopus development
爪蟾发育中的淀粉样蛋白、聚集体和核仁活性
基本信息
- 批准号:10170380
- 负责人:
- 金额:$ 30.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-05 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlzheimer like pathologyAlzheimer&aposs DiseaseAmyloidBiochemicalBiologicalCataractCell NucleolusCell NucleusCell divisionCell physiologyCellsCharacteristicsCytosolDNA DamageDNA-Directed RNA PolymeraseDevelopmentDiseaseEnsureEnvironmentEquilibriumExperimental ModelsFBXW7 geneFoundationsFractionationGelGene Expression RegulationGenetic ProcessesGenetic TranscriptionGenetic TranslationHomeostasisHormonesHuntington DiseaseImmunohistochemistryLiquid substanceMaintenanceMediatingMemoryMethodsMicroscopyModelingNPM1 geneNatureNormal CellNuclearOocytesOogenesisOrganellesPathogenesisPathologyPhasePhysiologicalPlayPost-Translational Protein ProcessingPropertyProteinsProteomicsRNARNA HelicaseRNA ProcessingRanaRecording of previous eventsRegulationRibosomal RNARibosomesRoleSolidStressStructureSystemTestingXenopus laevisXenopus oocyteamyloid formationbasebiological adaptation to stressdesignfibrillaringenetic informationhelicasein vivolong term memorynucleophosminparticleprotein aggregationprotein structureresponsetargeted treatmenttranscriptome sequencingtranscriptomicsxenopus development
项目摘要
Project Summary:
Many cellular processes critical for normal development have devastating consequences when they are
not controlled. Not too long ago, protein aggregation was largely equated with pathogenesis. More
recently we know that proteins aggregate to mediate stress responsiveness, cell division, long-term
memory and to self-assemble into critical non-membrane bound particles in the nucleus and cytosol. If
fact, at least 5% of known proteins have the composition that would allow them to form aggregates.
Lack of proper cellular control of protein aggregation leads to amyloid formation, which unregulated, is
part of the pathogenesis that accompanies devastating diseases like Alzheimer’s and Huntington’s
disease and common debilitating conditions like cataracts. The physical nature of aggregates may be
that of phase separated liquid droplets, gels, disordered aggregates and the ordered aggregates
characteristic of amyloid. Aggregates serve to greatly increase the local concentration of the
aggregating protein, and are one part of an equilibrium between different structural states.
Consequently, the ability and rate of proteins joining or leaving an aggregate is an important feature
that can be regulated, and if compromised leads to aggregate based pathology. There is a gap in
understanding which proteins participate in aggregate formation and how aggregation is regulated in
vivo. We propose that an ideal system to begin to bridge the gap would be the oocytes of the frog
Xenopus laevis. We and others have shown that aggregates accumulate during oogenesis in the
cytosol and in nucleus. The nuclear particles responsible for RNA transcription and processing by all
three RNA polymerases self-assemble into aggregates, generally with RNA as a co-aggregate. The
focus of this proposal is on nucleolus, a prominent non-membrane bound particle responsible for
synthesis and processing of ribosomal RNA, the manufacturing of ribosomes, helping to mediate
cellular responses to stress and DNA damage, and appropriately responding to cellular need for new
translational capacity. We use microscopy, immunohistochemistry, biochemical fractionation, protein
depletion, proteomic and transcriptomic analysis to understand the accumulation, function and stability
of the aggregates that establish nucleolar form and function. We take advantage of the unique
properties of Xenopus oocyte nuclei, including size, abundant protein and RNA content and ease of
manipulation to perform our studies. The findings will impact our understanding of how cells maintain
physiologically normal equilibrium between native and aggregating forms of proteins.
项目概要:
许多对正常发育至关重要的细胞过程如果被破坏,就会产生毁灭性的后果。
不久前,蛋白质聚集在很大程度上与发病机制等同。
最近我们知道蛋白质聚集可以调节应激反应、细胞分裂、长期
记忆并在细胞核和细胞质中自组装成关键的非膜结合颗粒。
事实上,至少 5% 的已知蛋白质具有允许它们形成聚集体的成分。
缺乏对蛋白质聚集的适当细胞控制会导致淀粉样蛋白的形成,而淀粉样蛋白的形成不受调节,
阿尔茨海默氏症和亨廷顿舞蹈症等毁灭性疾病的部分发病机制
疾病和常见的使人衰弱的病症,如白内障,聚集体的物理性质可能是。
相分离的液滴、凝胶、无序聚集体和有序聚集体
淀粉样蛋白的聚集特性可以大大增加淀粉样蛋白的局部浓度。
聚集蛋白质,并且是不同结构状态之间平衡的一部分。
经过测试,蛋白质加入或离开聚集体的能力和速率是一个重要特征
这是可以调节的,如果受到损害,就会导致基于聚合的病理学上存在差距。
了解哪些蛋白质参与聚集体形成以及聚集体是如何调节的
我们认为青蛙的卵母细胞是弥补这一差距的理想系统。
我们和其他人已经证明,聚集体在卵子发生过程中积累。
细胞质和细胞核中负责 RNA 转录和加工的核颗粒。
三种RNA聚合酶自组装成聚集体,通常以RNA作为共聚集体。
该提案的重点是核仁,一种重要的非膜结合颗粒,负责
核糖体 RNA 的合成和加工、核糖体的制造、帮助介导
细胞对压力和 DNA 损伤的反应,并适当地响应细胞对新物质的需求
我们使用显微镜、免疫组织化学、生化分级、蛋白质。
耗竭、蛋白质组和转录组分析,以了解积累、功能和稳定性
我们利用了独特的优势来建立核仁的形式和功能。
非洲爪蟾卵母细胞核的特性,包括大小、丰富的蛋白质和 RNA 含量以及易于分离
这些发现将影响我们对细胞如何维持的理解。
蛋白质的天然形式和聚集形式之间的生理正常平衡。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The ABCF gene family facilitates disaggregation during animal development.
ABCF 基因家族促进动物发育过程中的分解。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:3.3
- 作者:Skuodas, Sydney;Clemons, Amy;Hayes, Michael;Goll, Ashley;Zora, Betul;Weeks, Daniel L;Phillips, Bryan T;Fassler, Jan S
- 通讯作者:Fassler, Jan S
Component analysis of nucleolar protein compartments using Xenopus laevis oocytes.
使用非洲爪蟾卵母细胞对核仁蛋白区室进行成分分析。
- DOI:
- 发表时间:2022-08
- 期刊:
- 影响因子:0
- 作者:Lavering, Emily D;Petros, Irini N;Weeks, Daniel L
- 通讯作者:Weeks, Daniel L
Protein Aggregation and Disaggregation in Cells and Development.
细胞和发育中的蛋白质聚集和解聚。
- DOI:10.1016/j.jmb.2021.167215
- 发表时间:2021-10-15
- 期刊:
- 影响因子:5.6
- 作者:Fassler JS;Skuodas S;Weeks DL;Phillips BT
- 通讯作者:Phillips BT
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL L. WEEKS其他文献
DANIEL L. WEEKS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL L. WEEKS', 18)}}的其他基金
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
7987632 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
6992703 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
7159309 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
6719707 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
8110014 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
8469049 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
8269765 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
Nkx2-5 and congenital heart defects in Xenopus
Nkx2-5 与爪蟾先天性心脏缺陷
- 批准号:
6838792 - 财政年份:2004
- 资助金额:
$ 30.4万 - 项目类别:
相似国自然基金
环氧合酶-2代谢紊乱促进β-淀粉样蛋白在阿尔茨海默病中产生、传播和沉积的神经病理学机制研究
- 批准号:31571064
- 批准年份:2015
- 资助金额:60.0 万元
- 项目类别:面上项目
早老蛋白基因突变与阿尔茨海默病样tau病理学的实验研究
- 批准号:39970808
- 批准年份:1999
- 资助金额:13.0 万元
- 项目类别:面上项目
相似海外基金
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
- 批准号:
10667764 - 财政年份:2023
- 资助金额:
$ 30.4万 - 项目类别:
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
通过靶向 CCR5 预防 HIV 感染中的阿尔茨海默病样脑部病变
- 批准号:
10700624 - 财政年份:2023
- 资助金额:
$ 30.4万 - 项目类别:
Pericyte control of capillary perfusion in the Alzheimer's disease brain
阿尔茨海默病大脑中毛细血管灌注的周细胞控制
- 批准号:
10655813 - 财政年份:2023
- 资助金额:
$ 30.4万 - 项目类别:
Sleep abnormalities in Down Syndrome-related Alzheimer's disease
唐氏综合症相关阿尔茨海默病的睡眠异常
- 批准号:
10658057 - 财政年份:2023
- 资助金额:
$ 30.4万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 30.4万 - 项目类别: